Intelligence · Clinical Pipeline
Agios Netherlands Pipeline
All ClinicalTrials.gov programs at Agios Netherlands — phase, modality, and trial IDs.
- Programs
- 8
Quick answer
Agios Netherlands has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AG-348
Agios Netherlands B.V.
Pyruvate Kinase Deficiency
2 trials -
Mitapivat
Agios Netherlands B.V.
Sickle Cell Disease
2 trials -
Mitapivat
Agios Netherlands B.V.
Non-Transfusion-dependent Alpha-Thalassemia
1 trial -
Mitapivat
Agios Netherlands B.V.
Pediatric Pyruvate Kinase Deficiency
2 trials -
Mitapivat Matched Placebo
Agios Netherlands B.V.
Transfusion-dependent Alpha-Thalassemia
1 trial -
Placebo
Agios Netherlands B.V.
Pyruvate Kinase Deficiency
1 trial -
Placebo Matching Mitapivat
Agios Netherlands B.V.
Non-Transfusion-dependent Alpha-Thalassemia
1 trial -
Placebo Matching Mitapivat
Agios Netherlands B.V.
Transfusion-dependent Alpha-Thalassemia
1 trial
Frequently asked questions
How many pipeline programs does Agios Netherlands have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs